The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding
The up‐regulation of lectin‐like oxidized low‐density lipoprotein receptor‐1 (LOX‐1), encoded by the OLR1 gene, plays a fundamental role in the pathogenesis of atherosclerosis. Moreover, OLR1 polymorphisms were associated with increased susceptibility to acute myocardial infarction (AMI) and coronar...
Main Authors: | , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717858/ |
id |
pubmed-4717858 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-47178582016-01-26 The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding Morini, Elena Rizzacasa, Barbara Pucci, Sabina Polidoro, Chiara Ferrè, Fabrizio Caporossi, Daniela Helmer Citterich, Manuela Novelli, Giuseppe Amati, Francesca Short Communication The up‐regulation of lectin‐like oxidized low‐density lipoprotein receptor‐1 (LOX‐1), encoded by the OLR1 gene, plays a fundamental role in the pathogenesis of atherosclerosis. Moreover, OLR1 polymorphisms were associated with increased susceptibility to acute myocardial infarction (AMI) and coronary artery diseases (CAD). In these pathologies, the identification of therapeutic approaches that can inhibit or reduce LOX‐1 overexpression is crucial. Predictive analysis showed a putative hsa‐miR‐24 binding site in the 3′UTR of OLR1, ‘naturally’ mutated by the presence of the rs1050286 single nucleotide polymorphism (SNP). Luciferase assays revealed that miR‐24 targets OLR1 3′UTR‐G, but not 3′UTR‐A (P < 0.0005). The functional relevance of miR‐24 in regulating the expression of OLR1 was established by overexpressing miR‐24 in human cell lines heterozygous (A/G, HeLa) and homozygous (A/A, HepG2) for rs1050286 SNP. Accordingly, HeLa (A/G), but not HepG2 (A/A), showed a significant down‐regulation of OLR1 both at RNA and protein level. Our results indicate that rs1050286 SNP significantly affects miR‐24 binding affinity to the 3′UTR of OLR1, causing a more efficient post‐transcriptional gene repression in the presence of the G allele. On this basis, we considered that OLR1 rs1050286 SNP may contribute to modify OLR1 susceptibility to AMI and CAD, so ORL1 SNPs screening could help to stratify patients risk. John Wiley and Sons Inc. 2015-11-06 2016-01 /pmc/articles/PMC4717858/ /pubmed/26542080 http://dx.doi.org/10.1111/jcmm.12716 Text en © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Morini, Elena Rizzacasa, Barbara Pucci, Sabina Polidoro, Chiara Ferrè, Fabrizio Caporossi, Daniela Helmer Citterich, Manuela Novelli, Giuseppe Amati, Francesca |
spellingShingle |
Morini, Elena Rizzacasa, Barbara Pucci, Sabina Polidoro, Chiara Ferrè, Fabrizio Caporossi, Daniela Helmer Citterich, Manuela Novelli, Giuseppe Amati, Francesca The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding |
author_facet |
Morini, Elena Rizzacasa, Barbara Pucci, Sabina Polidoro, Chiara Ferrè, Fabrizio Caporossi, Daniela Helmer Citterich, Manuela Novelli, Giuseppe Amati, Francesca |
author_sort |
Morini, Elena |
title |
The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding |
title_short |
The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding |
title_full |
The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding |
title_fullStr |
The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding |
title_full_unstemmed |
The human rs1050286 polymorphism alters LOX‐1 expression through modifying miR‐24 binding |
title_sort |
human rs1050286 polymorphism alters lox‐1 expression through modifying mir‐24 binding |
description |
The up‐regulation of lectin‐like oxidized low‐density lipoprotein receptor‐1 (LOX‐1), encoded by the OLR1 gene, plays a fundamental role in the pathogenesis of atherosclerosis. Moreover, OLR1 polymorphisms were associated with increased susceptibility to acute myocardial infarction (AMI) and coronary artery diseases (CAD). In these pathologies, the identification of therapeutic approaches that can inhibit or reduce LOX‐1 overexpression is crucial. Predictive analysis showed a putative hsa‐miR‐24 binding site in the 3′UTR of OLR1, ‘naturally’ mutated by the presence of the rs1050286 single nucleotide polymorphism (SNP). Luciferase assays revealed that miR‐24 targets OLR1 3′UTR‐G, but not 3′UTR‐A (P < 0.0005). The functional relevance of miR‐24 in regulating the expression of OLR1 was established by overexpressing miR‐24 in human cell lines heterozygous (A/G, HeLa) and homozygous (A/A, HepG2) for rs1050286 SNP. Accordingly, HeLa (A/G), but not HepG2 (A/A), showed a significant down‐regulation of OLR1 both at RNA and protein level. Our results indicate that rs1050286 SNP significantly affects miR‐24 binding affinity to the 3′UTR of OLR1, causing a more efficient post‐transcriptional gene repression in the presence of the G allele. On this basis, we considered that OLR1 rs1050286 SNP may contribute to modify OLR1 susceptibility to AMI and CAD, so ORL1 SNPs screening could help to stratify patients risk. |
publisher |
John Wiley and Sons Inc. |
publishDate |
2015 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717858/ |
_version_ |
1613525481760489472 |